×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

  • Gurus
  • Other
  • RA CAPITAL MANAGEMENT, L.P. (Data extracted from 13F, 13D, 13G and Form 4)

RA CAPITAL MANAGEMENT, L.P.

AUM: $11.32 B
13-F Portfolio Value: $5.94 B
Last 13-F Filed: Q2 2025
Concentration in top 10: 66.19%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
VORVOR BIOPHARMA INC.1.00%1,988,657$60,455,1731,988,657New13D
ASMBAssembly Biosciences, Inc.0.57%1,530,615$36,122,5141,530,615New13G
LBRXLB PHARMACEUTICALS INC0.46%1,675,000$28,140,0001,675,000New13G
PALIPALISADE BIO, INC.0.28%9,935,761$16,890,7949,935,761New13G
HNGEHINGE HEALTH INC-A0.24%300,000$15,525,000300,000New$51.7513F
IVVDInvivyd, Inc.0.18%21,338,288$11,095,91021,338,288New13G
JBIOJADE BIOSCIENCES INC0.16%1,062,326$10,612,6371,062,326New$9.9913F
TNGXTANGO THERAPEUTICS INC0.16%2,000,000$10,240,0002,000,000New$5.1213F
CTNMContineum Therapeutics, Inc.0.15%2,122,000$9,230,7002,122,000New13G
SABSSAB Biotherapeutics, Inc.0.15%4,401,500$8,847,0154,401,500New13D
OMDAOMADA HEALTH INC0.11%400,000$7,320,000400,000New$18.313F
WGSGENEDX HOLDINGS CORP0.08%58,044$5,358,04258,044New$92.3113F
IFRXINFLARX NV0.02%1,973,233$1,558,8541,973,233New$0.7913F